Covid cases in Kerala likely to come down in next 2 weeks: AIIMS professor

Kerala has passed its COVID-19 peak and in the next 2 weeks, a decline in cases should start in the state, said Dr Sanjay Rai, AIIMS Professor on Tuesday.

Kerala
(File photo: PTI)
ANI General News
2 min read Last Updated : Sep 15 2021 | 9:14 AM IST

Kerala has passed its COVID-19 peak and in the next 2 weeks, a decline in cases should start in the state, said Dr Sanjay Rai, AIIMS Professor on Tuesday.

Rai told ANI, "Earlier sero survey in Kerala suggest that most population was susceptible but latest sero survey shows that 46 per cent had antibodies due to vaccine or by infection. The measures are taken by the state only slows down the spread. By looking at the data of the virus spread in last 2-3 months, Kerala has passed its peak and in the next 2 weeks, a decline in cases should start. Just like North-East, Kerala should also start witness drop in COVID cases by the start of October as per the epidemiological picture."

AIIMS will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon and the application has been put to seek the mandatory permission of the Ethics Committee.

"It is very early to say but we believe that future is promising for Nasal Vaccine as it can provide mucosal immunity, then infection prevention is possible. Most of the vaccines are not able to stop the infection, they only reduce the severity. The Nasal vaccine has gone for ethical approval and after the approval, we will start the trial," said Dr Rai, who is also Bharat Biotech's nasal vaccine clinical trial's principal investigator.

The adenoviral intranasal vaccine BBV154 is the first of its kind COVID-19 vaccine to undergo human trials in India.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAIIMSKerala

First Published: Sep 15 2021 | 9:14 AM IST

Next Story